Literature DB >> 27209182

Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials.

Landon W Trost1, John P Mulhall2.   

Abstract

INTRODUCTION: Male hypogonadism is a common condition, with an increasing body of literature on diagnosis, implications, and management. Given the significant variability in testosterone (T) from a physiologic and assay perspective, a thorough understanding of factors affecting T values and study methodology is essential to interpret reported study outcomes appropriately. However, despite the large number of publications on T, there are no reference materials consolidating all relevant and potentially confounding factors necessary to interpret T studies appropriately. AIMS: To create a resource document that reviews sources of T variability, free vs total T, assay techniques and questionnaires, and study methodology relevant to interpreting outcomes.
METHODS: A PubMed search was performed of all the T literature published on T variability, assay techniques, and T-specific questionnaires. Results were summarized in the context of their impact on interpreting T literature outcomes and methodology. MAIN OUTCOME MEASURES: Effect of various factors on T variability and their relevance to study methodology and outcomes.
RESULTS: Several factors affect measured T levels, including aging, circadian rhythms, geography, genetics, lifestyle choices, comorbid conditions, and intraindividual daily variability. The utility of free T over total T is debatable and must be compared using appropriate threshold levels. Among various assay techniques, mass spectrometry and equilibrium dialysis are gold standards. Calculated empirical estimates of free T also are commonly used and accepted. Hypogonadism-specific questionnaires have limited utility in screening for hypogonadism, and their role as objective end points for quantifying symptoms remains unclear. Numerous aspects of study methodology can directly or indirectly affect reported outcomes, including design (randomized, prospective, retrospective), duration, populations studied (age, comorbid conditions), low T threshold, therapeutic agent used, objective measurements and end points selected, and statistical interpretation.
CONCLUSION: Critical appraisal of the T literature requires an understanding of numerous factors resulting in T variability, study design and methodology, and limitations of assay techniques and objective measurement scales.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Androgen; Erectile Dysfunction; Hypogonadism; Libido; Measure; Steroid

Mesh:

Substances:

Year:  2016        PMID: 27209182      PMCID: PMC5516925          DOI: 10.1016/j.jsxm.2016.04.068

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  141 in total

1.  Effect of testosterone treatment on bone mineral density in men over 65 years of age.

Authors:  P J Snyder; H Peachey; P Hannoush; J A Berlin; L Loh; J H Holmes; A Dlewati; J Staley; J Santanna; S C Kapoor; M F Attie; J G Haddad; B L Strom
Journal:  J Clin Endocrinol Metab       Date:  1999-06       Impact factor: 5.958

2.  Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men.

Authors:  K W Smith; H A Feldman; J B McKinlay
Journal:  Clin Endocrinol (Oxf)       Date:  2000-12       Impact factor: 3.478

3.  Androgen therapy in women: an Endocrine Society Clinical Practice guideline.

Authors:  Margaret E Wierman; Rosemary Basson; Susan R Davis; Sundeep Khosla; Karen K Miller; William Rosner; Nanette Santoro
Journal:  J Clin Endocrinol Metab       Date:  2006-10-03       Impact factor: 5.958

4.  Serum androgen levels in black, Hispanic, and white men.

Authors:  Heather J Litman; Shalender Bhasin; Carol L Link; Andre B Araujo; John B McKinlay
Journal:  J Clin Endocrinol Metab       Date:  2006-08-15       Impact factor: 5.958

5.  Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials.

Authors:  Olga M Calof; Atam B Singh; Martin L Lee; Anne M Kenny; Randall J Urban; Joyce L Tenover; Shalender Bhasin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-11       Impact factor: 6.053

Review 6.  Testosterone and depression: systematic review and meta-analysis.

Authors:  Fahd Aziz Zarrouf; Steven Artz; James Griffith; Cristian Sirbu; Martin Kommor
Journal:  J Psychiatr Pract       Date:  2009-07       Impact factor: 1.325

7.  Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study.

Authors:  Gideon Sartorius; Sasa Spasevska; Amanda Idan; Leo Turner; Elise Forbes; Anna Zamojska; Carolyn A Allan; Lam P Ly; Ann J Conway; Robert I McLachlan; David J Handelsman
Journal:  Clin Endocrinol (Oxf)       Date:  2012-11       Impact factor: 3.478

Review 8.  Testosterone supplementation and sexual function: a meta-analysis study.

Authors:  Giovanni Corona; Andrea M Isidori; Jaques Buvat; Antonio Aversa; Giulia Rastrelli; Geoff Hackett; Vincenzo Rochira; Alessandra Sforza; Andrea Lenzi; Edoardo Mannucci; Mario Maggi
Journal:  J Sex Med       Date:  2014-04-04       Impact factor: 3.802

9.  A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men.

Authors:  Paul D Morris; Chris J Malkin; Kevin S Channer; T Hugh Jones
Journal:  Eur J Endocrinol       Date:  2004-08       Impact factor: 6.664

10.  A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation.

Authors:  Andrea D Coviello; Robin Haring; Melissa Wellons; Dhananjay Vaidya; Terho Lehtimäki; Sarah Keildson; Kathryn L Lunetta; Chunyan He; Myriam Fornage; Vasiliki Lagou; Massimo Mangino; N Charlotte Onland-Moret; Brian Chen; Joel Eriksson; Melissa Garcia; Yong Mei Liu; Annemarie Koster; Kurt Lohman; Leo-Pekka Lyytikäinen; Ann-Kristin Petersen; Jennifer Prescott; Lisette Stolk; Liesbeth Vandenput; Andrew R Wood; Wei Vivian Zhuang; Aimo Ruokonen; Anna-Liisa Hartikainen; Anneli Pouta; Stefania Bandinelli; Reiner Biffar; Georg Brabant; David G Cox; Yuhui Chen; Steven Cummings; Luigi Ferrucci; Marc J Gunter; Susan E Hankinson; Hannu Martikainen; Albert Hofman; Georg Homuth; Thomas Illig; John-Olov Jansson; Andrew D Johnson; David Karasik; Magnus Karlsson; Johannes Kettunen; Douglas P Kiel; Peter Kraft; Jingmin Liu; Östen Ljunggren; Mattias Lorentzon; Marcello Maggio; Marcello R P Markus; Dan Mellström; Iva Miljkovic; Daniel Mirel; Sarah Nelson; Laure Morin Papunen; Petra H M Peeters; Inga Prokopenko; Leslie Raffel; Martin Reincke; Alex P Reiner; Kathryn Rexrode; Fernando Rivadeneira; Stephen M Schwartz; David Siscovick; Nicole Soranzo; Doris Stöckl; Shelley Tworoger; André G Uitterlinden; Carla H van Gils; Ramachandran S Vasan; H-Erich Wichmann; Guangju Zhai; Shalender Bhasin; Martin Bidlingmaier; Stephen J Chanock; Immaculata De Vivo; Tamara B Harris; David J Hunter; Mika Kähönen; Simin Liu; Pamela Ouyang; Tim D Spector; Yvonne T van der Schouw; Jorma Viikari; Henri Wallaschofski; Mark I McCarthy; Timothy M Frayling; Anna Murray; Steve Franks; Marjo-Riitta Järvelin; Frank H de Jong; Olli Raitakari; Alexander Teumer; Claes Ohlsson; Joanne M Murabito; John R B Perry
Journal:  PLoS Genet       Date:  2012-07-19       Impact factor: 5.917

View more
  23 in total

1.  1H NMR-based metabonomics for infertility diagnosis in men with varicocele.

Authors:  Filipe Tenorio Lira Neto; Ronmilson Alves Marques; Alexandre de Freitas Cavalcanti Filho; Leslie Clifford Noronha Araujo; Salvador Vilar Correia Lima; Licarion Pinto; Ricardo Oliveira Silva
Journal:  J Assist Reprod Genet       Date:  2020-07-26       Impact factor: 3.412

Review 2.  Varicoceles in the pediatric population: Diagnosis, treatment, and outcomes.

Authors:  Thomas de Los Reyes; Jennifer Locke; Kourosh Afshar
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

3.  Testosterone Recovery Profiles After Cessation of Androgen Deprivation Therapy for Prostate Cancer.

Authors:  Bruno Nascimento; Eduardo P Miranda; Lawrence C Jenkins; Nicole Benfante; Elizabeth A Schofield; John P Mulhall
Journal:  J Sex Med       Date:  2019-05-09       Impact factor: 3.802

4.  Association of total and calculated free testosterone with androgen deficiency symptoms in patients with type 2 diabetes.

Authors:  Biswas Anupam; Channabasappa Shivaprasad; Atluri Sridevi; Yalamanchi Aiswarya; Kolla Gautham; Barure Ramdas; Shah Kejal
Journal:  Int J Impot Res       Date:  2019-04-18       Impact factor: 2.896

Review 5.  Testosterone therapy in children and adolescents: to whom, how, when?

Authors:  Maria Camila Suarez A; Joseph M Israeli; Eliyahu Kresch; Leon Telis; Daniel E Nassau
Journal:  Int J Impot Res       Date:  2022-01-07       Impact factor: 2.896

6.  High C-reactive protein is associated with increased risk of biochemical hypogonadism: a population-based cohort study.

Authors:  Amar Osmancevic; Kristin Ottarsdottir; Margareta Hellgren; Ulf Lindblad; Bledar Daka
Journal:  Endocr Connect       Date:  2022-06-24       Impact factor: 3.221

Review 7.  The Variability and Determinants of Testosterone Measurements in Children: A Critical Review.

Authors:  Jessa Rose Li; Xan Goodman; June Cho; Diane Holditch-Davis
Journal:  Biol Res Nurs       Date:  2021-05-18       Impact factor: 2.318

8.  Baseline Gonadotropin Levels and Testosterone Response in Hypogonadal Men Treated With Clomiphene Citrate.

Authors:  Sorena Keihani; Lindsey N Wright; Nathan J Alder; Jinfeng Jiang; Philip J Cheng; Gregory J Stoddard; Alexander W Pastuszak; Christopher M Deibert; James M Hotaling
Journal:  Urology       Date:  2020-04-28       Impact factor: 2.649

Review 9.  Advances in stem cell research for the treatment of primary hypogonadism.

Authors:  Lu Li; Vassilios Papadopoulos
Journal:  Nat Rev Urol       Date:  2021-06-29       Impact factor: 14.432

10.  An Approach to Nonsuppressed Testosterone in Transgender Women Receiving Gender-Affirming Feminizing Hormonal Therapy.

Authors:  Arvind Maheshwari; Todd Nippoldt; Caroline Davidge-Pitts
Journal:  J Endocr Soc       Date:  2021-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.